ITF Research Pharma, S.L.U.   Report issue

For profit Phase 2
Founded: Berwyn PA United States (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2015
NCT02413008
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

estriol (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1